MODERATOR
:
SPEAKER
(S):
Dr. Zbigniew Szczepiorkowski, MD, PhD, FCAP, Medical Director, Transfusion Medicine Service, Dartmouth-Hitchcock Medical Center
Lynn O'Donnell, PhD, Director, Cell Therapy Laboratory, The Ohio State University, James Cancer Hospital
Lizette Caballero, MLS (ASCP)CM, Senior Supervisor, UCSF BMT Laboratory
Description
This session will describe induction, consolidation and maintenance chemotherapy and how theses phases of the treatment will affect the collection of stem cells. Speakers will discuss in detail the different regimens in preparation for collection, type of mobilization, available growth factors, timing for collection and the collection process. They will also talk about the final product composition depending on mobilization regimen.
LEARNER OUTCOMES:
-
Compare the effects of mobilization regimens and the collection process on the composition of the final product and how various regimens may affect product processing.
-
Describe the differences behind induction, consolidation, salvage, maintenance and other chemotherapies used to achieve remission.
-
Describe the different priming regimens used for the mobilization of peripheral blood stem cells in preparation for collection.
-
Review the process of peripheral stem cell collection by apheresis and differences between devices, diseases and collection goals (e.g. large volume collections).
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.